soul trial oral semaglutide cardiovascular outcomes results 2025 Study Finds Vastly Reduces Heart Attacks, Strokes SOUL trial shows oral semaglutide

25 June 2025 Drugs like Ozempic might seem like the latest fad but people can take comfort that this class of medications has been around for decades, writes Dr Natalie Nanayakkara, Endocrinologist and researcher at the Baker Heart and Diabetes Institute

The clinical results justify the hype

A third might send 15 mg/mL

Due to biological activity,GLP-1(7-37)will be released several minutes after glucose or food intake, having blood glucose concentration-dependent hypoglycemic effect

It creates a timeline you can share with your clinician so dose changes and side effects like constipation or yeast symptoms can be better understood